Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: April 2018
Filing Date: April 19, 2018
Principal Executive Offices: Else-Kröner Strasse 1, 61346 Bad Homburg, Germany
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a procedural filing to furnish exhibits rather than a financial results report.
Material Changes
No material financial changes or operational updates are disclosed in this filing. The document contains no comparative data versus prior periods.
Guidance, Outlook, and Risks
Management Commentary: None provided in this filing.
Guidance/Outlook: Not applicable.
Risks/Contingencies: Not applicable.
Unusual Items: The filing includes Exhibit 99.1, which is a Voting Instruction Card for holders of American Depositary Receipts (ADRs).
Key Facts for Investor Verification
- This Form 6-K is a procedural filing to deliver a Voting Instruction Card (Exhibit 99.1) to ADR holders.
- The document does not contain financial statements, earnings results, or operational metrics.
- Investors should refer to the company's Form 20-F or quarterly press releases for financial performance data.
- The filing was signed by Rice Powell (CEO) and Michael Brosnan (CFO) on behalf of the General Partner.